Heavy Metals, Estrogenics Among Research Priorities For FDA's Cosmetics Office
This article was originally published in The Rose Sheet
Executive Summary
FDA’s Office of Cosmetics and Colors continues with surveys to detect the presence of controversial ingredients in cosmetics, including asbestos in talc-containing products. Office’s Deputy Director Patricia Hansen provides an overview at the Personal Care Products Council’s recent scientific summit.